Risperidone in the treatment of Tourette syndrome: A double-blind, placebo-controlled trial

Journal of Clinical Psychopharmacology

Volumn 22, Issue 1, 2002, Pages 31-39

  Dion, Yves ^a   Annable, Lawrence ^a   Sandor, Paul ^a   Chouinard, Guy ^a  

^a Allan Memorial Institute   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RISPERIDONE;

ADOLESCENT; ADULT; AKATHISIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; HYPOKINESIA; MALE; OBSESSION; PARKINSONISM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SOMNOLENCE; TREMOR;

ADOLESCENT; ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; RISPERIDONE; TOURETTE SYNDROME; TREATMENT OUTCOME;

EID: 0036157416     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200202000-00006     Document Type: Article

References (56)

1. Neurochemical and some related psychopharmacological aspects of Tourette's syndrome: An update
2. Tic-like behaviours induced by TRH-amide: Differential effects of ritanserin and haloperidol
3. Behavioural profile of alpha-MSH: Differential effects of ritanserin, haloperidol and clonidine
4. Behavioural profile of ACTH(1-39): Differential effects of haloperidol and ritanserin
5. A survey of Tourette syndrome patients and their families: The 1987 Ohio Tourette Survey
6. Subtle and underrecognized side effects of neuroleptic treatment in children with Tourette syndrome
7. Treatment of Tourette syndrome with neuroleptic drugs
8. Current drug therapy for Tourette's syndrome
9. Neuroleptic drugs
10. A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome
11. Tourette syndrome: A follow-up study
12. Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourette's syndrome
13. ECG changes during haloperidol and pimozide treatment of Tourette's disorder
14. Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6)
15. Clonidine and clonazepam in Tourette syndrome
16. A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome
17. Controlled Study of pimozide vs placebo in Tourette's Syndrome
18. Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder
19. Effects of pimozide and cognition in children with Tourette Syndrome: Interaction with comorbid attention-deficit hyperactivity disorder
20. New pharmacological approaches in the treatment of Tourette syndrome
21. Fhiphenazine and multifocal tic disorders
22. The trial use of clozapine for abnormal involuntary movement disorders
23. Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride
24. Management of Gilles de la Tourette syndrome using sulpiride
25. Pharmacology of risperidone (R64766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonist properties
26. The biochemical profile of risperidone, a new antipsychotic
27. Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: A multicentre double-blind comparative study
28. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients
29. Risperidone: Clinical safety and efficacy in schizophrenia
30. Effects of risperidone in tardive dyskinesia: An analysis of the Canadian multicenter risperidone study
31. In vivo dopamine-D2 and serotonin-5-HT2 receptor binding study of risperidone and haloperidol
32. Serotonin-dopamine antagonist and Gilles de la Tourette's syndrome: An open pilot dose-titration study with risperidone
33. Risperidone treatment of children and adolescents with chronic tic disorders: A preliminary report
34. Risperidone as a treatment for Tourette's syndrome
35. Risperidone in the treatment of Tourette syndrome: A retrospective case note study
36. The Yale-Brown Obsessive Compulsive Scale (Y-BOCS): Part I. Development, use and reliability
37. The Yale-Brown Obsessive Compulsive Scale (Y-BOCS): Part II. Validity
38. The extrapyramidal symptom rating scale
39. Methods for the quantitative assessment of depressive and manic behavior
40. Covariance analyses with heterogeneity of slopes in fixed models
41. Diagnosis and classification of tics and Tourette Syndrome
42. Selection and use of diagnostic and clinical rating instruments
43. The role of gender differences in the reduction of etiologic heterogeneity in schizophrenia
44. Tourette's syndrome: A genetically predisposed and an environmentally specified developmental psychopathology
45. Alternative hypotheses on the inheritance of Tourette syndrome
46. Subtle and under-recognized side effects of neuroleptic treatment in children with Tourette's Disorder
47. Tourette syndrome, pimozide, and school phobia: The neuroleptic separation anxiety syndrome
48. Paradoxical reactions in children associated with midazolam use during endoscopy
49. Diazepam-induced disinhibition
50. Bromazepam and lorazepam in generalized anxiety: A placebo-controlled study with measurement of drug plasma concentrations
51. Risperidone vs haloperidol for prevention of relapse in schizophrenia and schizoaffective disorders: A long-term double-blind comparison
52. Risperidone compared with both lithium and haloperidol in mania: A double-blind randomized controlled trial
53. Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome - A functional approach
54. Risperidone in the treatment of affective illness and obsessive-compulsive disorder